Table 3. The relationship between gastric cancer and multiple tumor markers stratified by gender.

Tumor markers	Gender	Gastric cancer (n = 268)	Control (n = 209)	χ2	OR 95% CI	P
/	Female Male	70	113
/		198	96	38.787	3.329 [2.265–4.893]	<0.001
AFP-	Female	60	105
	Male	165	94
AFP+	Female	10	8
	Male	33	2	15.043	3.803 [1.862–7.767]	<0.001
NSE−	Female	62	110
	Male	179	89
NSE+	Female	8	3	4.592	2.229 [1.054–4.717]	0.038
	Male	19	7
FER−	Female	67	113
	Male	185	86
FER+	Female	3	0	4.924	/	0.054
	Male	13	10	1.330	0.604 [0.255–1.433]	0.249
CEA−	Female	55	109
	Male	146	90
CEA+	Female	15	4	35.449	6.633 [3.318–13.261]	<0.001
	Male	52	6
CA125−	Female	54	104
	Male	161	95
CA125+	Female	16	9	23.022	4.906 [2.429–9.905]	<0.001
	Male	37	1
CA153−	Female	66	109
	Male	191	90
CA153+	Female	4	4	0.129	0.852 [0.355–2.046]	0.719
	Male	7	6
CA199−	Female	54	104
	Male	150	95
CA199+	Female	16	9	8.128	3.424 [1.420–8.257]	0.004
	Male	48	1	25.057	30.400 [4.127–223.928]	<0.001
CA242−	Female	54	104
	Male	149	95
CA242+	Female	16	9	8.128	3.424 [1.644–4.446]	0.004
	Male	49	1	25.741	31.242 [4.243–230.043]	<0.001

Note:

OR, odds ratio; CI, confidence interval.